Inhibitory Effect of r-Hirudin Variant III on Streptozotocin-Induced Diabetic Cataracts in Rats

The in vivo inhibitory effect of r-hirudin variant III (rHV3) on streptozotocin (STZ)-induced diabetic cataracts in rats was investigated. SD-rats were firstly made diabetic by a single intraperitoneal injection of 2% (W/V) STZ (65 mg/kg). Two weeks later, cataract formation was examined by slit lam...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaojian Gong, Qiuyan Zhang, Shuhua Tan
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2013/630651
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555339595120640
author Xiaojian Gong
Qiuyan Zhang
Shuhua Tan
author_facet Xiaojian Gong
Qiuyan Zhang
Shuhua Tan
author_sort Xiaojian Gong
collection DOAJ
description The in vivo inhibitory effect of r-hirudin variant III (rHV3) on streptozotocin (STZ)-induced diabetic cataracts in rats was investigated. SD-rats were firstly made diabetic by a single intraperitoneal injection of 2% (W/V) STZ (65 mg/kg). Two weeks later, cataract formation was examined by slit lamp microscope, and the cataracted animals were randomly grouped. The animals in the treated groups received rHV3 drops administration to the eyes with various doses. After 4 weeks treatment, the animals were sacrificed to evaluate the biochemical changes of aldose reductase (AR), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and malondialdehyde (MDA) levels in the eye lens. Meanwhile, the cataract progression was monitored by slit lamp microscope. As a result, rHV3 drops treatment significantly increased the activities of SOD and GSH-Px in the lens in a dose-dependent manner, whereas AR activity and MDA level in the lens were dramatically decreased. Also, the morphological observation further confirmed the inhibition of the development of STZ-induced diabetic cataracts by the rHV3 drops treatment. Thus, our data suggest that rHV3 drops are pharmacologically effective for the protection against STZ-induced diabetic cataracts in rats.
format Article
id doaj-art-61fe3fb21fae4e8d97ce7aca5669e0fc
institution Kabale University
issn 1537-744X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-61fe3fb21fae4e8d97ce7aca5669e0fc2025-02-03T05:48:29ZengWileyThe Scientific World Journal1537-744X2013-01-01201310.1155/2013/630651630651Inhibitory Effect of r-Hirudin Variant III on Streptozotocin-Induced Diabetic Cataracts in RatsXiaojian Gong0Qiuyan Zhang1Shuhua Tan2Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, ChinaDepartment of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, ChinaState Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, ChinaThe in vivo inhibitory effect of r-hirudin variant III (rHV3) on streptozotocin (STZ)-induced diabetic cataracts in rats was investigated. SD-rats were firstly made diabetic by a single intraperitoneal injection of 2% (W/V) STZ (65 mg/kg). Two weeks later, cataract formation was examined by slit lamp microscope, and the cataracted animals were randomly grouped. The animals in the treated groups received rHV3 drops administration to the eyes with various doses. After 4 weeks treatment, the animals were sacrificed to evaluate the biochemical changes of aldose reductase (AR), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and malondialdehyde (MDA) levels in the eye lens. Meanwhile, the cataract progression was monitored by slit lamp microscope. As a result, rHV3 drops treatment significantly increased the activities of SOD and GSH-Px in the lens in a dose-dependent manner, whereas AR activity and MDA level in the lens were dramatically decreased. Also, the morphological observation further confirmed the inhibition of the development of STZ-induced diabetic cataracts by the rHV3 drops treatment. Thus, our data suggest that rHV3 drops are pharmacologically effective for the protection against STZ-induced diabetic cataracts in rats.http://dx.doi.org/10.1155/2013/630651
spellingShingle Xiaojian Gong
Qiuyan Zhang
Shuhua Tan
Inhibitory Effect of r-Hirudin Variant III on Streptozotocin-Induced Diabetic Cataracts in Rats
The Scientific World Journal
title Inhibitory Effect of r-Hirudin Variant III on Streptozotocin-Induced Diabetic Cataracts in Rats
title_full Inhibitory Effect of r-Hirudin Variant III on Streptozotocin-Induced Diabetic Cataracts in Rats
title_fullStr Inhibitory Effect of r-Hirudin Variant III on Streptozotocin-Induced Diabetic Cataracts in Rats
title_full_unstemmed Inhibitory Effect of r-Hirudin Variant III on Streptozotocin-Induced Diabetic Cataracts in Rats
title_short Inhibitory Effect of r-Hirudin Variant III on Streptozotocin-Induced Diabetic Cataracts in Rats
title_sort inhibitory effect of r hirudin variant iii on streptozotocin induced diabetic cataracts in rats
url http://dx.doi.org/10.1155/2013/630651
work_keys_str_mv AT xiaojiangong inhibitoryeffectofrhirudinvariantiiionstreptozotocininduceddiabeticcataractsinrats
AT qiuyanzhang inhibitoryeffectofrhirudinvariantiiionstreptozotocininduceddiabeticcataractsinrats
AT shuhuatan inhibitoryeffectofrhirudinvariantiiionstreptozotocininduceddiabeticcataractsinrats